Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19

  • Eric J. Lenze
    Department of Psychiatry, School of Medicine, Washington University in St Louis, St Louis, Missouri
  • Caline Mattar
    Division of Infectious Diseases, Department of Internal Medicine, School of Medicine, Washington University in St Louis, St Louis, Missouri
  • Charles F. Zorumski
    Department of Psychiatry, School of Medicine, Washington University in St Louis, St Louis, Missouri
  • Angela Stevens
    Department of Psychiatry, School of Medicine, Washington University in St Louis, St Louis, Missouri
  • Julie Schweiger
    Department of Psychiatry, School of Medicine, Washington University in St Louis, St Louis, Missouri
  • Ginger E. Nicol
    Department of Psychiatry, School of Medicine, Washington University in St Louis, St Louis, Missouri
  • J. Philip Miller
    Division of Biostatistics, Informatics Institute, School of Medicine, Washington University in St Louis, St Louis, Missouri
  • Lei Yang
    Department of Psychiatry, School of Medicine, Washington University in St Louis, St Louis, Missouri
  • Michael Yingling
    Department of Psychiatry, School of Medicine, Washington University in St Louis, St Louis, Missouri
  • Michael S. Avidan
    Department of Anesthesiology, School of Medicine, Washington University in St Louis, St Louis, Missouri
  • Angela M. Reiersen
    Department of Psychiatry, School of Medicine, Washington University in St Louis, St Louis, Missouri

Bibliographic Information

Other Title
  • A Randomized Clinical Trial

Journal

  • JAMA

    JAMA 324 (22), 2292-, 2020-12-08

    American Medical Association (AMA)

Citations (5)*help

See more

Report a problem

Back to top